Organovo Holdings Company Profile (NASDAQ:ONVO)

About Organovo Holdings (NASDAQ:ONVO)

Organovo Holdings logoOrganovo Holdings, Inc. is an early commercial-stage company focused on developing and commercializing functional human tissues. The Company focuses on the generation of three-dimensional (3D) human tissues, by utilizing its platform technology to create human tissue constructs in 3D. It is focused on development of products, including 3D human tissues used for the preclinical assessment of drug effects, including applications in predictive toxicology, absorption, distribution, metabolism, excretion (ADME), and drug metabolism and pharmacokinetics (DMPK); customized human tissues as living, dynamic models of human biology or disease, for use in drug discovery and development, and three-dimensional human tissues for clinical applications, such as blood vessels for bypass grafting, nerve grafts for nerve damage repair and functional tissue patches for the repair or replacement of damaged tissues and organs.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology & Medical Research
  • Sub-Industry: N/A
  • Symbol: NASDAQ:ONVO
  • CUSIP: N/A
  • Web: www.organovo.com
Capitalization:
  • Market Cap: $165.55 million
  • Outstanding Shares: 106,123,000
Average Prices:
  • 50 Day Moving Avg: $2.04
  • 200 Day Moving Avg: $2.47
  • 52 Week Range: $1.46 - $4.08
P/E:
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -4.35
  • P/E Growth: 0.00
Sales & Book Value:
  • Annual Revenue: $4.33 million
  • Price / Sales: 36.27
  • Book Value: $0.54 per share
  • Price / Book: 2.74
Profitability:
  • EBITDA: ($38,770,000.00)
  • Net Margins: -918.97%
  • Return on Equity: -65.49%
  • Return on Assets: -60.15%
Debt:
  • Current Ratio: 15.72%
  • Quick Ratio: 15.60%
Misc:
  • Average Volume: 1.05 million shs.
  • Beta: 3.02
  • Short Ratio: 21.68
 

Frequently Asked Questions for Organovo Holdings (NASDAQ:ONVO)

What is Organovo Holdings' stock symbol?

Organovo Holdings trades on the NASDAQ under the ticker symbol "ONVO."

How were Organovo Holdings' earnings last quarter?

Organovo Holdings, Inc. (NASDAQ:ONVO) issued its quarterly earnings data on Wednesday, August, 9th. The company reported ($0.10) earnings per share (EPS) for the quarter, meeting the Thomson Reuters' consensus estimate of ($0.10). The business earned $0.99 million during the quarter, compared to analysts' expectations of $0.92 million. Organovo Holdings had a negative return on equity of 65.49% and a negative net margin of 918.97%. The company's revenue for the quarter was up 11.1% on a year-over-year basis. View Organovo Holdings' Earnings History.

When will Organovo Holdings make its next earnings announcement?

Organovo Holdings is scheduled to release their next quarterly earnings announcement on Wednesday, November, 1st 2017. View Earnings Estimates for Organovo Holdings.

Where is Organovo Holdings' stock going? Where will Organovo Holdings' stock price be in 2017?

4 equities research analysts have issued 12 month price objectives for Organovo Holdings' stock. Their predictions range from $3.75 to $15.00. On average, they expect Organovo Holdings' share price to reach $6.94 in the next year. View Analyst Ratings for Organovo Holdings.

Who are some of Organovo Holdings' key competitors?

Who are Organovo Holdings' key executives?

Organovo Holdings' management team includes the folowing people:

  • Taylor J. Crouch, President, Chief Executive Officer
  • Eric Michael David M.D. J.D., Executive Vice President - Pre-Clinical Development, Chief Strategy Officer
  • Sharon Collins Presnell Ph.D., Chief Scientific Officer
  • Jennifer Kinsbruner Bush J.D., Compliance Officer, General Counsel, Corporate Secretary
  • Paul Gallant, General Manager
  • Richard Maroun, Director
  • Robert F. Baltera Jr., Lead Independent Director
  • James T. Glover, Independent Director
  • Richard A. Heyman Ph.D., Independent Director
  • Tamar D. Howson, Independent Director

How do I buy Organovo Holdings stock?

Shares of Organovo Holdings can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Organovo Holdings' stock price today?

One share of Organovo Holdings stock can currently be purchased for approximately $1.48.


MarketBeat Community Rating for Organovo Holdings (NASDAQ ONVO)
Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  62 (Vote Outperform)
Underperform Votes:  71 (Vote Underperform)
Total Votes:  133
MarketBeat's community ratings are surveys of what our community members think about Organovo Holdings and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Organovo Holdings (NASDAQ:ONVO) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 4 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $6.94 (368.75% upside)
Consensus Price Target History for Organovo Holdings (NASDAQ:ONVO)
Price Target History for Organovo Holdings (NASDAQ:ONVO)
Analysts' Ratings History for Organovo Holdings (NASDAQ:ONVO)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
9/26/2017Jefferies Group LLCReiterated RatingBuy$4.00HighView Rating Details
6/9/2017Evercore ISIReiterated RatingOutperform$4.00 -> $3.75LowView Rating Details
1/25/2017Raymond James Financial, Inc.Initiated CoverageOutperform$5.00N/AView Rating Details
12/15/2016BTIG ResearchInitiated CoverageBuy$15.00N/AView Rating Details
(Data available from 10/17/2015 forward)

Earnings

Earnings History for Organovo Holdings (NASDAQ:ONVO)
Earnings by Quarter for Organovo Holdings (NASDAQ:ONVO)
Earnings History by Quarter for Organovo Holdings (NASDAQ ONVO)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/1/2017($0.10)N/AView Earnings Details
8/9/2017Q1 2018($0.10)($0.10)$0.92 million$0.99 millionViewListenView Earnings Details
6/7/2017Q4 2017($0.11)($0.10)$0.76 million$0.80 millionViewListenView Earnings Details
2/9/2017Q3 2017($0.10)($0.09)$1.40 million$1.15 millionViewListenView Earnings Details
11/3/2016Q217($0.11)($0.10)$0.50 million$1.38 millionViewListenView Earnings Details
8/4/2016Q1($0.10)($0.09)$0.30 million$0.89 millionViewListenView Earnings Details
6/9/2016Q4($0.11)($0.09)$0.10 million$0.55 millionViewListenView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Organovo Holdings (NASDAQ:ONVO)
2018 EPS Consensus Estimate: ($0.10)
2019 EPS Consensus Estimate: ($0.32)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q3 20181($0.10)($0.10)($0.10)
Q1 20191($0.09)($0.09)($0.09)
Q2 20191($0.09)($0.09)($0.09)
Q3 20191($0.07)($0.07)($0.07)
Q4 20191($0.07)($0.07)($0.07)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Organovo Holdings (NASDAQ:ONVO)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Organovo Holdings (NASDAQ:ONVO)
Insider Ownership Percentage: 10.20%
Institutional Ownership Percentage: 23.94%
Insider Trades by Quarter for Organovo Holdings (NASDAQ:ONVO)
Institutional Ownership by Quarter for Organovo Holdings (NASDAQ:ONVO)
Insider Trades by Quarter for Organovo Holdings (NASDAQ:ONVO)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
2/9/2017Keith MurphyCEOSell25,000$3.68$92,000.00View SEC Filing  
1/24/2017Keith MurphyCEOSell25,000$3.51$87,750.00View SEC Filing  
12/14/2016Keith MurphyCEOSell50,000$3.72$186,000.00View SEC Filing  
8/5/2016Eric DavidEVPSell20,000$4.55$91,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Organovo Holdings (NASDAQ:ONVO)
Latest Headlines for Organovo Holdings (NASDAQ:ONVO)
Source:
DateHeadline
americanbankingnews.com logoOrganovo Holdings, Inc. (ONVO) Stock Rating Upgraded by Zacks Investment Research
www.americanbankingnews.com - October 15 at 11:32 PM
americanbankingnews.com logoCritical Review: Organovo Holdings (ONVO) & Its Rivals
www.americanbankingnews.com - October 13 at 2:20 PM
finance.yahoo.com logoETFs with exposure to Organovo Holdings, Inc. : October 9, 2017
finance.yahoo.com - October 9 at 8:48 PM
americanbankingnews.com logoQ3 2018 EPS Estimates for Organovo Holdings, Inc. Decreased by Analyst (ONVO)
www.americanbankingnews.com - October 9 at 5:56 AM
americanbankingnews.com logoOrganovo Holdings, Inc. (ONVO) Given Average Rating of "Hold" by Brokerages
www.americanbankingnews.com - October 8 at 9:00 AM
finance.yahoo.com logoOrganovo Holdings, Inc. :ONVO-US: Earnings Analysis: Q1, 2018 By the Numbers : October 6, 2017
finance.yahoo.com - October 6 at 9:11 AM
seekingalpha.com logoOrganovo to cut 13% of workforce, announces preliminary revenues - Seeking Alpha
seekingalpha.com - October 5 at 1:56 PM
americanbankingnews.com logoOrganovo Holdings, Inc. (ONVO) Receives "Buy" Rating from Jefferies Group LLC
www.americanbankingnews.com - September 26 at 8:56 PM
seekingalpha.com logoThe Competitive Case For Organovo Holdings - Seeking Alpha
seekingalpha.com - September 22 at 7:31 AM
americanbankingnews.com logoJefferies Group LLC Reiterates "Buy" Rating for Organovo Holdings, Inc. (ONVO)
www.americanbankingnews.com - September 14 at 7:16 PM
americanbankingnews.com logoOrganovo Holdings, Inc. (ONVO) Given Average Recommendation of "Hold" by Analysts
www.americanbankingnews.com - September 13 at 9:34 AM
reuters.com logoBRIEF-Organovo says Keith Murphy submitted resignation as chairman of board‍
www.reuters.com - August 29 at 6:23 AM
businesswire.com logoGlobal 3D Bioprinting Market Outlook to 2022 - Focus on Technology, Application and Materials - Research and Markets
www.businesswire.com - August 26 at 8:01 AM
nasdaq.com logoOrganovo Sponsors Pioneering Research With Amgen and Medikine in Critical Areas of Liver and Kidney Disease - Nasdaq
www.nasdaq.com - August 23 at 9:49 AM
finance.yahoo.com logoOrganovo Sponsors Pioneering Research With Amgen and Medikine in Critical Areas of Liver and Kidney Disease
finance.yahoo.com - August 23 at 9:49 AM
americanbankingnews.com logoOrganovo Holdings, Inc. (ONVO) Receives Consensus Rating of "Buy" from Analysts
www.americanbankingnews.com - August 19 at 9:02 AM
americanbankingnews.com logoQ3 2018 Earnings Forecast for Organovo Holdings, Inc. (NASDAQ:ONVO) Issued By Jefferies Group
www.americanbankingnews.com - August 14 at 7:54 AM
finance.yahoo.com logoETFs with exposure to Organovo Holdings, Inc. : August 11, 2017
finance.yahoo.com - August 12 at 6:36 AM
americanbankingnews.com logoOrganovo Holdings, Inc. (ONVO) Announces Earnings Results, Hits Estimates
www.americanbankingnews.com - August 11 at 9:58 PM
finance.yahoo.com logoOrganovo Holdings Revenue Is Growing at a Snail's Pace Compared With Prior Quarters
finance.yahoo.com - August 11 at 7:16 AM
finance.yahoo.com logoInvestor Network: Organovo Holdings, Inc. to Host Earnings Call
finance.yahoo.com - August 10 at 6:29 AM
finance.yahoo.com logoOrganovo Announces Fiscal First-Quarter 2018 Results; Company Affirms Full-Year Fiscal 2018 Outlook
finance.yahoo.com - August 10 at 6:29 AM
finance.yahoo.com logoEdited Transcript of ONVO earnings conference call or presentation 9-Aug-17 9:00pm GMT
finance.yahoo.com - August 10 at 6:29 AM
finance.yahoo.com logoOrganovo reports 1Q loss
finance.yahoo.com - August 10 at 6:29 AM
streetinsider.com logoOrganovo (ONVO) Secures 3-Yr $1.7M Grants from National Institutes of Health to Study Liver Disease
www.streetinsider.com - August 1 at 5:34 AM
streetinsider.com logoOrganovo (ONVO) Secures 3-Yr $1.7M Grants from National Institutes of Health to Study Liver Disease - StreetInsider.com
www.streetinsider.com - August 1 at 12:31 AM
finance.yahoo.com logoOrganovo and UC San Diego Receive $1.7 Million Grant From National Institutes of Health to Study Liver Disease
finance.yahoo.com - August 1 at 12:31 AM
finance.yahoo.com logoETFs with exposure to Organovo Holdings, Inc. : July 31, 2017
finance.yahoo.com - August 1 at 12:31 AM
americanbankingnews.com logoOrganovo Holdings, Inc. (ONVO) Short Interest Down 7.2% in July
www.americanbankingnews.com - July 28 at 1:24 AM
americanbankingnews.com logoOrganovo Holdings, Inc. (NASDAQ:ONVO) Rating Reiterated by Jefferies Group LLC
www.americanbankingnews.com - July 27 at 5:55 PM
americanbankingnews.com logo$880,000.00 in Sales Expected for Organovo Holdings, Inc. (NASDAQ:ONVO) This Quarter
www.americanbankingnews.com - July 20 at 11:44 AM
finance.yahoo.com logoOrganovo Announces Release Date for Fiscal First-Quarter 2018 Financial Results
finance.yahoo.com - July 19 at 12:55 AM
fool.com logoHow Risky Is Organovo Holdings, Inc.?
www.fool.com - July 18 at 4:13 PM
seekingalpha.com logoOrganovo - Going The Right Direction - Seeking Alpha
seekingalpha.com - July 15 at 7:12 AM
finance.yahoo.com logoETFs with exposure to Organovo Holdings, Inc. : July 13, 2017
finance.yahoo.com - July 14 at 7:09 AM
finance.yahoo.com logoHere's Why Organovo Holdings Inc Fell 10.5% in June
finance.yahoo.com - July 11 at 6:24 AM
finance.yahoo.com logoETFs with exposure to Organovo Holdings, Inc. : July 3, 2017
finance.yahoo.com - July 4 at 2:59 AM
fool.com logo3 Reasons Organovo Holdings, Inc. Stock Could Fall Even More
www.fool.com - June 22 at 4:32 PM
globenewswire.com logoOrganovo to Present at Jefferies Healthcare Conference - GlobeNewswire (press release)
www.globenewswire.com - June 5 at 7:39 PM
prnewswire.com logoResearch Reports Initiation on Medical Labs Stocks -- Organovo, DexCom, Quest ...
www.prnewswire.com - May 9 at 11:17 AM
thestreet.com logoClearside Biomedical, Inc. Announces Completion Of Patient Enrollment In Phase 1/2 Open Label Clinical Trial Of CLS-TA In Diabetic Macular Edema
www.thestreet.com - April 20 at 9:07 AM
fool.com logoOrganovo Holdings CEO Leaves: Should Investors Be Worried? - Motley Fool
www.fool.com - April 14 at 8:03 AM
fool.com logoWhat's Next for Organovo Holdings Inc.? - Motley Fool
www.fool.com - April 12 at 7:59 PM
usatoday.com logo2 inmates charged with killing 4 in South Carolina prison - USA TODAY
www.usatoday.com - April 8 at 6:17 PM
nytimes.com logoTrump Shifts Course on Egypt, Praising Its Authoritarian Leader - New York Times
www.nytimes.com - April 3 at 6:24 PM
nytimes.com logoChina Learns How to Get Trump's Ear: Through Jared Kushner - New York Times
www.nytimes.com - April 2 at 10:53 AM
usatoday.com logoSenate panel to vote on Supreme Court nominee Neil Gorsuch - USA TODAY
www.usatoday.com - April 2 at 10:53 AM
cnn.com logoMichael Flynn left Russian speaking fees off initial financial disclosures - CNN
www.cnn.com - April 2 at 10:53 AM
foxnews.com logoPart of I-85 collapses in Atlanta after massive fire
www.foxnews.com - March 31 at 12:21 AM
abcnews.go.com logoWhite House adviser Jared Kushner to appear before Senate Intelligence Committee
abcnews.go.com - March 27 at 9:55 AM

Social

Chart

Organovo Holdings (ONVO) Chart for Tuesday, October, 17, 2017

This page was last updated on 10/17/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.